Evidence map›Paper›PMID 30920214›Full record

ArticleJournal of chemical information and modeling2019

Ligand-Based Virtual Screening Using Graph Edit Distance as Molecular Similarity Measure.

Carlos Garcia-Hernandez, Alberto Fernández, Francesc Serratosa

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ligand-Based Virtual Screening Based on the Graph Edit Distance.International journal of molecular sciences · 2021
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlos Garcia-HernandezDepartament d'Enginyeria Química , Universitat Rovira i Virgili , Tarragona , Catalunya 43007 , Spain.ORCID 0000-0002-3130-4539
Alberto FernándezDepartament d'Enginyeria Química , Universitat Rovira i Virgili , Tarragona , Catalunya 43007 , Spain.ORCID 0000-0002-1241-1646
Francesc SerratosaDepartament d'Enginyeria Informàtica i Matemàtiques , Universitat Rovira i Virgili , Tarragona , Catalunya 43007 , Spain.ORCID 0000-0001-6112-5913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended reduced graphs provide summary representations of chemical structures using pharmacophore-type node descriptions to encode the relevant molecular properties. Commonly used similarity measures using reduced graphs convert these graphs into 2D vectors like fingerprints, before chemical comparisons are made. This study investigates the effectiveness of a graph-only driven molecular comparison by using extended reduced graphs along with graph edit distance methods for molecular similarity calculation as a tool for ligand-based virtual screening applications, which estimate the bioactivity of a chemical on the basis of the bioactivity of similar compounds. The results proved to be very stable and the graph editing distance method performed better than other methods previously used on reduced graphs. This is exemplified with six publicly available data sets: DUD-E, MUV, GLL&GDD, CAPST, NRLiSt BDB, and ULS-UDS. The screening and statistical tools available on the ligand-based virtual screening benchmarking platform and the RDKit were also used. In the experiments, our method performed better than other molecular similarity methods which use array representations in most cases. Overall, it is shown that extended reduced graphs along with graph edit distance is a combination of methods that has numerous applications and can identify bioactivity similarities in a structurally diverse group of molecules.

Indexed as

Computer GraphicsComputational BiologyDrug Evaluation, PreclinicalLigandsModels, MolecularMolecular ConformationUser-Computer InterfaceLigands

Identifiers

PMID30920214
PMCPMC6668628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.